Rating History for UroGen Pharma (URGN) by Jefferies
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/9/2026 | Amin Makarem | New Coverage | Buy (N/A) |
40.00 (N/A) |
19.10 (36.80) |
92.67% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/9/2026 | Amin Makarem | New Coverage | Buy (N/A) |
40.00 (N/A) |
19.10 (36.80) |
92.67% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||